Neumega recombinant human interleukin-11 data

The Cambridge, Mass., company presented Phase I results in breast cancer patients treated with cyclophosphamide and doxorubicin, showing a dose-related increase in platelet counts in all patients, with none of the fever or chills associated with other cytokines.

Patients reported muscle and joint pain and fatigue, and displayed treatment-related anemia. These effects were also dose-dependent, increasing with the highest dose tested. ...